Bayer asks rivals for HIV & hepatitis diagnostic rights
This article was originally published in Clinica
Executive Summary
Bayer Diagnostics has gone to four of its rivals - Johnson & Johnson's Ortho-Clinical Diagnostics, Chiron, Roche Diagnostics and Dade Behring - in order to secure vital rights to HIV O and hepatitis C (HCV) tests to boost the marketability of its ADVIA Centaur immunoassay platform in infectious disease diagnosis.